User:Z3418340: Difference between revisions

Revision as of 23:52, 12 August 2014

Embryology --Z3418340 (talk) 12:45, 6 August 2014 (EST)

Lab Attendance

Lab 1 - --Z3418340 (talk) 12:53, 6 August 2014 (EST)

Lab Assessment

ARTICLE 1 <pubmed>25077107 </pubmed>

Effect of Vitamin D status on clinical pregnancy rates following in vitro fertilisation.

The investigation was carried out on IVF patients from Mount Sinai Hospital, Toronto, Ontario. Candidates selected for the study were aged 18-41 years, with base line levels of FSH (on Day 3 of Cycle) and the ability to provide informed consent. Researchers included 173 female patients, who then underwent IVF cycles as per standard procedure.

Serum 25-hydroxy-vitamin D (25[OH]D) levels were measured one week prior to oocyte retrieval, these measurements taken in order to determine the initial Vitamin D status. Patients were either classified as having sufficient (≥ 75 nmol/L) or insufficient (< 75 nmol/L) 25(OH)D levels.

Standard IVF procedures followed; oocyte retrieval, fertilisation, growth and embryo transfer. An ultrasound was then taken 4-5 weeks after the embryo was transferred and implantation success was monitored, as indicate by the presence of a gestational sac, visible by ultrasonography. The implantation rate was calculated as the number of gestational sacs observed by ultrasonography divided by the number of embryos transferred, multiplied by 100.

With in this cohort 45.1% had sufficient levels of 25(OH)D, while 54.9% had insufficient levels. The study found a 52.5% clinical pregnancy rate per IVF cycle among women with sufficient levels of 25(OH)D levels. This was significantly higher than compare to a rate of 34.7% the among women with insufficient levels of 25(OH)D. Further more an insufficient levels of 25(OH)D was also associated with delayed implantation,

Pub Med

[1] PubMed

http://www.ncbi.nlm.nih.gov/pubmed/25084016

@@ Line 1: / Line 1: @@
 Embryology
 --[[User:Z3418340|Z3418340]] ([[User talk:Z3418340|talk]]) 12:45, 6 August 2014 (EST)
 ==Lab Attendance==
 Lab 1 - --[[User:Z3418340|Z3418340]] ([[User talk:Z3418340|talk]]) 12:53, 6 August 2014 (EST)
+==Lab Assessment ==
+ARTICLE 1  <pubmed>25077107 </pubmed>
+Effect of Vitamin D status on clinical pregnancy rates following in vitro fertilisation.
+The investigation was carried out on IVF patients from Mount Sinai Hospital, Toronto, Ontario. Candidates selected for the study were aged 18-41 years, with base line levels of FSH (on Day 3 of Cycle) and the ability to provide informed consent. Researchers included 173 female patients, who then underwent IVF cycles as per standard procedure.
+Serum 25-hydroxy-vitamin D (25[OH]D) levels were measured one week prior to oocyte retrieval, these measurements taken in order to determine the initial Vitamin D status. Patients were either classified as having sufficient (≥ 75 nmol/L) or insufficient (< 75 nmol/L) 25(OH)D levels.
+Standard IVF procedures followed; oocyte retrieval, fertilisation, growth and embryo transfer. An ultrasound was then taken 4-5 weeks after the embryo was transferred and implantation success was monitored, as indicate by the presence of a gestational sac, visible by ultrasonography. The implantation rate was calculated as the number of gestational sacs observed by ultrasonography divided by the number of embryos transferred, multiplied by 100.
+With in this cohort 45.1% had sufficient levels of 25(OH)D, while 54.9% had insufficient levels.
+The study found a 52.5% clinical pregnancy rate per IVF cycle among women with sufficient levels of 25(OH)D levels. This was significantly higher than compare to a rate of 34.7% the among women with insufficient levels of 25(OH)D. Further more an insufficient levels of 25(OH)D was also associated with delayed implantation,
+==Pub Med==
 [http://www.ncbi.nlm.nih.gov/pubmed ]
 [http://www.ncbi.nlm.nih.gov/pubmed PubMed]